Author:
Fotaki N.,Aivaliotis A.,Butler J.,Dressman J.,Fischbach M.,Hempenstall J.,Klein S.,Reppas C.
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference33 articles.
1. FDA (Food and Drug Administration), Center for Drug Evaluation and Research (CDER), Guidance for Industry Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations, 1997.
2. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations;Uppoor;J. Control. Release,2001
3. Site-specific release of anti-inflammatory drugs in the gastrointestinal tract: an in vitro model;Klein;J. Pharm. Pharmacol.,2005
4. In vitro vs. canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis;Fotaki;Eur. J. Pharm. Sci.,2005
5. E. Jantratid, V. De Maio, E. Ronda, V. Mattavelli, J. Dressman, In vitro correlation analysis of modified release diclofenac sodium pellets, AAPS Annual Meeting, San Diego CA, USA, 2007.
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献